Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Best of the 2005 AUA Annual Meeting: Highlights from the 2005 Annual Meeting of the American Urological Association, May 21-May 26, 2005, San Antonio, TX.

× No keyword cloud information.

14 in total

1. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men.

Authors: R O Roberts; M M Lieber; T Rhodes; C J Girman; D G Bostwick; S J Jacobsen
Journal: Urology Date: 1998-04 Impact factor: 2.649

2. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

Authors: M W Kattan; J A Eastham; A M Stapleton; T M Wheeler; P T Scardino
Journal: J Natl Cancer Inst Date: 1998-05-20 Impact factor: 13.506

3. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.

Authors: Thomas A Stamey; Iain M Johnstone; John E McNeal; Arthur Y Lu; Cheryl M Yemoto
Journal: J Urol Date: 2002-01 Impact factor: 7.450

4. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.

Authors: A W Partin; M W Kattan; E N Subong; P C Walsh; K J Wojno; J E Oesterling; P T Scardino; J D Pearson
Journal: JAMA Date: 1997-05-14 Impact factor: 56.272

5. Use of the novel marker BLCA-1 for the detection of bladder cancer.

Authors: Julie M Myers-Irvin; Doug Landsittel; Robert H Getzenberg
Journal: J Urol Date: 2005-07 Impact factor: 7.450

6. Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials.

Authors: Richard J Sylvester; Adrian P M van der Meijden; J Alfred Witjes; Karlheinz Kurth
Journal: J Urol Date: 2005-07 Impact factor: 7.450

7. Molecular classification of doxazosin-induced alterations in the rat prostate using gene expression profiling.

Authors: Makoto Yono; Harris E Foster; David Shin; Shrikant Mane; Jamshid Latifpour
Journal: Life Sci Date: 2005-02-05 Impact factor: 5.037

8. Inconsistent localization of gram-positive bacteria to prostate-specific specimens from patients with chronic prostatitis.

Authors: John N Krieger; Susan O Ross; Ajit P Limaye; Donald E Riley
Journal: Urology Date: 2005-10 Impact factor: 2.649

9. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.

Authors: J I Epstein; P C Walsh; M Carmichael; C B Brendler
Journal: JAMA Date: 1994-02-02 Impact factor: 56.272

10. Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?

Authors: M J Barry; W O Williford; Y Chang; M Machi; K M Jones; E Walker-Corkery; H Lepor
Journal: J Urol Date: 1995-11 Impact factor: 7.450